Tanger director granted 5,207 restricted shares
SKERRITT SUSAN E reported acquisition or exercise transactions in this Form 4 filing.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Filing Summary
SKERRITT SUSAN E reported acquisition or exercise transactions in this Form 4 filing.
Tanger Inc. director Susan E. Skerritt received an award of 5,207 shares of common stock as a grant under the company’s Amended and Restated Incentive Award Plan. These restricted shares vest, and restrictions lapse, on February 15, 2027, with potential accelerated vesting in certain cases such as death or certain involuntary terminations.
Following this grant, Skerritt directly holds 50,721.82 common shares. A footnote also notes that 1,432.83 deferred share units were accumulated through a dividend reinvestment program since her last Form 4, reflecting additional stock-based compensation accrual rather than open-market purchases.
Insider Trade Summary
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Grant/Award | Common Stock | 5,207 | $0.00 | $0.00 |
Footnotes (2)
- F1. Represents a grant of restricted common shares under Tanger Inc.'s Amended and Restated Incentive Award Plan. The restricted common shares vest and the restrictions cease to apply on February 15, 2027 (subject to accelerated vesting in certain cases, such as death and certain involuntary terminations).
- F2. Since the Reporting Person's last Form 4, 1,432.83 deferred share units were acquired through a dividend reinvestment program.
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What did Tanger Inc. (SKT) director Susan E. Skerritt report in this Form 4?
AI-generated analysis. How Rhea-AI works. Not financial advice.